News from immunovaccine inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Oct 08, 2012, 10:00 ET

Immunovaccine Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com

 Immunovaccine Inc., (TSX-V: IMV), a clinical stage vaccine company, announced that their October 4th RetailInvestorConferences.com...

Oct 02, 2012, 12:39 ET

Immunovaccine Inc. to Webcast, Live, at RetailInvestorConferences.com on October 4th

Immunovaccine Inc., (TSX-V: IMV), a clinical stage vaccine company, announced that John Trizzino, chief executive officer and director, will...

Aug 05, 2009, 09:00 ET

ImmunoVaccine Technologies Partners With Scancell to Advance DNA Vaccine Delivery

HALIFAX, NS, Aug. 5 /PRNewswire/ - ImmunoVaccine Technologies Inc. (IVT), a Canadian vaccine development company, has signed an agreement with...

Jul 14, 2009, 09:00 ET

ImmunoVaccine Technologies Licenses Immunotope's Breast, Ovarian and Prostate Cancer Antigens

HALIFAX, NS, July 14 /PRNewswire/ - ImmunoVaccine Technologies Inc. (IVT), a vaccine development company, has entered into an agreement to...

May 26, 2009, 06:00 ET

ImmunoVaccine Technologies Partners with FIT Biotech to advance a therapeutic HIV vaccine

HALIFAX, NS, May 26 /PRNewswire/ - ImmunoVaccine Technologies Inc. (IVT), a Canadian vaccine development company, announced a research partnership...

May 20, 2009, 10:57 ET

ImmunoVaccine Technologies Collaborates with NRC Institute for Biodiagnostics Atlantic to measure effectiveness of DepoVax(TM) with novel MRI Imaging

HALIFAX, May 20 /PRNewswire/ - ImmunoVaccine Technologies Inc. (IVT), a vaccine development company, has announced a collaboration agreement with...

Apr 14, 2009, 09:00 ET

ImmunoVaccine Technologies Collaborates with Defence Research Development Canada to Strengthen Canada's Ability to Deal with Biological Threats

HALIFAX, April 14 /PRNewswire/ - ImmunoVaccine Technologies Inc. (IVT), a vaccine development company, has announced the signing of a 3-year...

Mar 27, 2009, 09:00 ET

ImmunoVaccine Technologies Signs Agreement with La Jolla Institute for Allergy & Immunology to Test the Application of DepoVax(TM) Technology to Battle Influenza

HALIFAX, March 27 /PRNewswire/ - ImmunoVaccine Technologies Inc. (IVT), a vaccine development company, has signed an agreement with the La Jolla...

Feb 25, 2009, 09:00 ET

ImmunoVaccine Technologies Signs Agreement with National Institutes of Health to Explore Vaccines for HIV and Malaria

HALIFAX, NS, Feb. 25 /PRNewswire/ - ImmunoVaccine Technologies Inc. (IVT), a vaccine development company, has signed a collaborative agreement with...

Jan 09, 2009, 10:00 ET

ImmunoVaccine Technologies Presents at OneMed Place Finance Forum

HALIFAX, NS, Jan. 9 /PRNewswire/ - ImmunoVaccine Technologies Inc. (IVT), a vaccine development company, announced today that it will present at...

May 23, 2008, 01:00 ET

ImmunoVaccine Technologies Congratulates Dr. Ramila Philip as One of PA's Best 50 Women in Business

HALIFAX, May 23 /PRNewswire/ - ImmunoVaccine Technologies Inc. (IVT), a vaccine development company, congratulates Dr. Ramila Philip for being...

Apr 30, 2008, 01:00 ET

ImmunoVaccine Technologies Patents DepoVax(TM) Vaccine Platform

HALIFAX, April 30 /PRNewswire/ - ImmunoVaccine Technologies Inc. (IVT), a vaccine development company, unveiled today its DepoVax(TM) platform, a...

Feb 20, 2008, 00:00 ET

ImmunoVaccine Technologies appoints the Honourable Michael Kirby as Chair

HALIFAX, Feb. 20 /PRNewswire/ - ImmunoVaccine Technologies Inc. (IVT), a vaccine development company, announced today the appointment of former...

Jan 23, 2008, 00:00 ET

ImmunoVaccine Technologies Discusses Phase I Clinical Trial Application

HALIFAX, Jan. 23 /PRNewswire/ - ImmunoVaccine Technologies Inc. (IVT) announced today that it has met with Health Canada's regulatory affairs...

Jan 21, 2008, 00:00 ET

ImmunoVaccine Technologies Receives $3 Million From ACOA

HALIFAX, Jan. 21 /PRNewswire/ - ImmunoVaccine Technologies Inc. (IVT), a clinical stage vaccine development company, will receive $3 Million from...

Jan 14, 2008, 00:00 ET

ImmunoVaccine Technologies licenses the VacciMax(R) platform to Pfizer Animal Health for future animal vaccine applications

HALIFAX, Jan. 14 /PRNewswire/ - ImmunoVaccine Technologies Inc. (IVT), announced today that it had signed licensing agreements for Pfizer Animal...

Jan 07, 2008, 00:00 ET

ImmunoVaccine Technologies to Present at OneMed Place Finance Forum

HALIFAX, Jan. 7 /PRNewswire/ - ImmunoVaccine Technologies Inc. (IVT), a vaccine enhancement company, announced today that it will present at the...

Dec 10, 2007, 00:00 ET

ImmunoVaccine Technologies Inc. to Acquire Immunotope Inc.

HALIFAX, Dec. 10 /PRNewswire/ - ImmunoVaccine Technologies Inc. (IVT), a Nova Scotia-based vaccine enhancement company, has signed a binding...

Nov 29, 2007, 00:00 ET

ImmunoVaccine Technologies Inc. Completes Scale-Up of VacciMax(R) to Commercially Relevant Scale

HALIFAX, Nov. 29 /PRNewswire/ - ImmunoVaccine Technologies Inc. (IVT) announced today that it has successfully scaled-up the manufacturing...

Sep 27, 2007, 01:00 ET

ImmunoVaccine Technologies Inc. Nears Phase I Clinical Trials with Completion of Scientific Advisory Board

HALIFAX, Sept. 27 /PRNewswire/ - ImmunoVaccine Technologies Inc. (IVT) finalizes an important step in its progress with the last appointment to...

Organizations in the News

The organizations with the most activity in PR Newswire's News Room

ReportBuyer
Research and Markets
Investor-Edge